Following years of bureaucratic hurdles, the first Food and Drug Administration-approved, randomized controlled trial on cannabis and post-traumatic stress disorder (PTSD) is set to begin this summer.
A year after legalization, cannabis tax revenues in the state have topped expectations and sales top $1.4 million per day.